-
Mashup Score: 0Pharmalittle: Biotech investors push to extend time before Medicare price negotiations; RiteAid closings could cause pharmacy deserts - 7 month(s) ago
Biopharma investors, who lobbied against allowing Medicare to negotiate drug prices, are trying a new tactic to preserve profits.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: People with obesity harmed by exclusion from studies; Teva sues Colorado over 'unconstitutional' program - 7 month(s) ago
People with obesity often go underrepresented in drug trials, a critical gap that researchers say leaves doctors unsure of efficacy or risks in that population.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 5Women biomedical inventors underrepresented on patents - 7 month(s) ago
Stanford Medicine-led study finds a disparity between men and women listed on patents and their research contributions.
Source: scopeblog.stanford.eduCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: Novo faces patent challenge on Wegovy and Ozempic; Senate panel moves to address drug shortages - 7 month(s) ago
A U.S. Patent Office tribunal agreed to review the validity of a Novo Nordisk patent related to its blockbuster drugs Ozempic and Wegovy.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: FDA finds ‘potential systemic bias’ in Amgen cancer drug trial; drugmakers organize to push back on antitrust reviews - 7 month(s) ago
A study of Amgen’s Lumakris may reflect systemic biases, the FDA said ahead of a meeting to determine whether the drug should stay on the market.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Pharmalittle: Court allows Medicare drug price negotiation to proceed; J&J will not enforce patents on key TB drug - 7 month(s) ago
A federal judge allowed the new Medicare drug price negotiation program to proceed while the court deliberates whether it is constitutional.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries - 7 month(s) ago
In an unexpected turnabout, Johnson & Johnson announced it would not enforce any of its patents for a key tuberculosis medicine in 134 low- and
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: Deadline looms for drugmakers to negotiate with Medicare; GOP senator probes 340B program at two hospitals - 7 month(s) ago
The deadline for drugmakers to sign agreements to negotiate with Medicare on pricing is this Sunday.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Pharmalittle: Amazon Pharmacy offers insulin discounts; DOJ blasts industry attempt to delay Medicare drug-price talks - 9 month(s) ago
Amazon Pharmacy will begin automatically applying manufacturer coupons to more than 14 insulin products.
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Pharmalittle: Wegovy heart study has docs seeing new possibilities; drugmakers file more 'continuation' patents that sideline generic rivals - 9 month(s) ago
Good morning, everyone, and how are you today? We are doing just fine, thank you. Given that this is already the middle of the week and we have survived
Source: www.statnews.comCategories: General Medicine News, Latest HeadlinesTweet
Pharmalot.. Pharmalittle.. Good Morning: Biotech investors push to extend time before Medicare price negotiations; RiteAid closings could cause pharmacy deserts & More news.. https://t.co/3Ti6ULN6fC #pharma #obesity #weightloss #patents #HIV #AIDS #Medicare $TEVA $RAD $NVO $LLY